Literature DB >> 9145746

Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases.

B McCarron1, W C Love.   

Abstract

Nontyphoidal salmonellal cholecystitis is a rare complication of nontyphoidal salmonellal enterocolitis. We describe three patients with this complication who were hospitalized in a regional infectious disease unit at Ruchill Hospital, Glasgow, Scotland, over a period of 12 months. All three patients were receiving ciprofloxacin therapy before the episodes of cholecystitis became clinically evident, and all required surgical intervention.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145746     DOI: 10.1093/clind/24.4.707

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.

Authors:  Antti J Hakanen; Marianne Lindgren; Pentti Huovinen; Jari Jalava; Anja Siitonen; Pirkko Kotilainen
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.

Authors:  T Guillard; E Cambau; F Chau; L Massias; C de Champs; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2013-09-09       Impact factor: 5.191

3.  Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test.

Authors:  A Hakanen; P Kotilainen; J Jalava; A Siitonen; P Huovinen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

4.  Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.

Authors:  Ernesto Liebana; Carol Clouting; Claire A Cassar; Luke P Randall; Rachel A Walker; E John Threlfall; Felicity A Clifton-Hadley; Anne M Ridley; Robert H Davies
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

Review 5.  Acute acalculous cholecystitis.

Authors:  Philip S Barie; Soumitra R Eachempati
Journal:  Curr Gastroenterol Rep       Date:  2003-08

6.  Clinical predictors of severe gallbladder complications in acute acalculous cholecystitis.

Authors:  Ay-Jiun Wang; Tsang-En Wang; Ching-Chung Lin; Shee-Chan Lin; Shou-Chuan Shih
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia.

Authors:  A Hakanen; P Kotilainen; P Huovinen; H Helenius; A Siitonen
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

8.  Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.

Authors:  Nicolas Allou; Emmanuelle Cambau; Laurent Massias; Françoise Chau; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

9.  Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals.

Authors:  C Heurtin-Le Corre; P Y Donnio; M Perrin; M F Travert; J L Avril
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar enteritidis: involvement of RamA and other global regulators.

Authors:  Edel O'Regan; Teresa Quinn; Jean-Marie Pagès; Matthew McCusker; Laura Piddock; Séamus Fanning
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.